Experimental Medicine in ADHD - Cannabinoids

NCT02249299 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

DRUG: Sativex Oromucosal Spray
DRUG: Placebo

Sponsor

King's College London

Collaborators

[object Object]